<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01683513</url>
  </required_header>
  <id_info>
    <org_study_id>Dr. Decleer W</org_study_id>
    <nct_id>NCT01683513</nct_id>
  </id_info>
  <brief_title>Trial Comparing hCG Triggering Versus GnRH Agonist Triggering in PCOS Patients</brief_title>
  <official_title>Prospective Randomized Trial on GnRH Agonist Triggering Versus hCG Triggering in IVF Stimulation in PCOS Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AZ Jan Palfijn Gent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Onze Lieve Vrouw Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>AZ Jan Palfijn Gent</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators compare the traditional way of triggering with a new way in
      patients with Poly Cystic Ovary Syndrome (PCOS). This to reduce the risque of Ovary Hyper
      Stimulation Syndrome (OHSS) in In Vitro Fertilization/ IntraCytoplastic Sperm Injection (IVF/
      ICSI) treatment. The investigators also compare the number of mature oocytes, embryo's and
      pregnancy rate.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2011</start_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MII oocytes</measure>
    <time_frame>patients will be followed during the stimulation with an average of 10 days</time_frame>
    <description>The number of mature oocytes retrieved after stimulation without creating OHSS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>2 Pro Nuclei (2PN) fertilization</measure>
    <time_frame>24h after ICSI</time_frame>
    <description>laboratory follow up of the fertilized egg during the first 24h</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>implantation rate</measure>
    <time_frame>12 weeks</time_frame>
    <description>The number of pregnancies obtained wich still is the most important issue for the patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OHSS</measure>
    <time_frame>one month with oocyte retrieval in the middle</time_frame>
    <description>patient follow up according to subjective complaints and objective measures</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Infertility</condition>
  <condition>PCOS</condition>
  <arm_group>
    <arm_group_label>humaan chorion gonadotropine</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>ovulation induction with 5000E hCG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GnRH agonist + 1500E hCG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ovulation induction with GnRH agonist and 1500E hCG one hour after egg retrieval</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GnRh agonist +1500E hCG</intervention_name>
    <description>ovulation induction with GnRh agonist and 1500E hCG one hour after egg retrieval</description>
    <arm_group_label>GnRH agonist + 1500E hCG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ICSI patients below 38 years

          -  1, 2 and 3e IVF cycle

          -  Body Mass Index (BMI) less than 32

          -  PCOS patients

        Exclusion Criteria:

          -  endocrinal diseases or problems
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wim Decleer, gynecologist</last_name>
    <role>Principal Investigator</role>
    <affiliation>IVF Centrum Jan Palfijn Gent</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wim Decleer</last_name>
    <phone>0032 9 3259220</phone>
    <email>wim.decleer@janpalfijngent.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paul Devroey</last_name>
    <phone>0032 9 2248070</phone>
    <email>ivf.studie@janpalfijngent.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AZ Jan Palfijn</name>
      <address>
        <city>Gent</city>
        <state>Oost-vlaanderen</state>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wim Decleer, gynecologist</last_name>
      <phone>0032 9 2248853</phone>
      <email>wim.decleer@janpalfijngent.be</email>
    </contact>
    <contact_backup>
      <phone>0032 9 2248851</phone>
      <email>ivf.studie@janpalfijngent.be</email>
    </contact_backup>
    <investigator>
      <last_name>Wim Decleer, gynecologist</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kaan Osamanagaoglu, gynecologist, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2012</study_first_submitted>
  <study_first_submitted_qc>September 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2012</study_first_posted>
  <last_update_submitted>March 20, 2017</last_update_submitted>
  <last_update_submitted_qc>March 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>AZ Jan Palfijn Gent</investigator_affiliation>
    <investigator_full_name>Dr. Decleer Wim</investigator_full_name>
    <investigator_title>gynecologist</investigator_title>
  </responsible_party>
  <keyword>OHSS</keyword>
  <keyword>mataphase II oocytes (MII)</keyword>
  <keyword>good quality embryo's</keyword>
  <keyword>pregnancy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deslorelin</mesh_term>
    <mesh_term>Triptorelin Pamoate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

